Clinical Trials Logo

Clinical Trial Summary

The prevalence of heart failure (HF) is constantly increasing in France due to the aging of the population, better management of etiological factors and improved treatments (drug / interventional). On the other hand, re-hospitalizations for heart failure continue to increase, exceeding reception capacities and constitute a real challenge for current public health systems. The PRADO system provides administrative support (through a health insurance advisor) in the management of patient appointments with their doctors as well as home visits by a nurse trained in heart failure. Other interventional medical and educational interventions performed during an out-of-hospital consultation guided by a computer platform would help to optimize the care and continuity of care.


Clinical Trial Description

The aim of this study is to demonstrate the value of a multiple intervention program in reducing early readmissions for heat failure in patients hospitalized for cardiac decompensation. This work will create an interventional assistance program to structure the exit consultation in order to optimize treatment, educate patients, ensure the continuity of hospital-city care and improve compliance (reminders) to reduce re-hospitalizations. This program will be carried out by using a computer platform allowing the systematization of output documents and the sending of messages (e-mail / SMS) for making appointments (medical consultations, biologicals sampling) and perfect therapeutic education. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04703504
Study type Interventional
Source French Cardiology Society
Contact Arnaud GALAT, MD
Phone +33 1 49 81 22 53
Email arnault.galat@aphp.fr
Status Recruiting
Phase N/A
Start date July 15, 2022
Completion date April 30, 2026

See also
  Status Clinical Trial Phase
Completed NCT05747820 - Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
Recruiting NCT02051985 - Early-start Exercise Training in Subacute Heart Failure N/A
Terminated NCT02859636 - Pronostic Value of Endothelial Dysfunction in Heart Failure N/A
Completed NCT00813202 - An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure Phase 3
Withdrawn NCT00166010 - Effects of Nesiritide in Pediatric Patients With Heart Failure N/A
Completed NCT00364416 - Longitudinal Registry for Advanced Heart Failure Patients N/A
Completed NCT00366639 - Registry for Acute Decompensated Heart Failure Patients N/A
Completed NCT00288730 - A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest Phase 3
Completed NCT03515980 - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function Phase 1
Completed NCT00475852 - A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure Phase 3
Completed NCT00510601 - Treating Congestive Heart Failure Using a Device to Remove Cholesterol Phase 0
Completed NCT00364325 - Registry for Acute Decompensated Heart Failure Patients Admitted to the ER N/A
Withdrawn NCT02649998 - Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF N/A
Not yet recruiting NCT02324400 - Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients Phase 1/Phase 2
Completed NCT00259038 - Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure Phase 2
Completed NCT00271557 - A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels Phase 3
Completed NCT03730961 - An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic Phase 2
Completed NCT06255418 - Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart Failure
Terminated NCT04198779 - Interest of the Smartphone Application "MonCÅ“ur" in the Follow-up of Patients With Heart Failure N/A
Completed NCT04698954 - Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients N/A